| Year |
Citation |
Score |
| 2021 |
Porazzi P, Petruk S, Pagliaroli L, De Dominici M, Deming D, Puccetti MV, Kushinsky S, Kumar G, Minieri V, Barbieri E, Deliard S, Grande A, Trizzino M, Gardini A, Canaani E, ... ... Calabretta B, et al. Targeting chemotherapy to de-condensed H3K27me3-marked chromatin of AML cells enhances leukemia suppression. Cancer Research. PMID 34903608 DOI: 10.1158/0008-5472.CAN-21-1297 |
0.34 |
|
| 2020 |
Silvestri G, Trotta R, Stramucci L, Ellis JJ, Harb JG, Neviani P, Wang S, Eisfeld AK, Walker CJ, Zhang B, Srutova K, Gambacorti-Passerini C, Pineda G, Jamieson CHM, Stagno F, ... ... Calabretta B, et al. Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on Antiproliferative and PP2A-Activating Functions. Blood Cancer Discovery. 1: 48-67. PMID 32974613 DOI: 10.1158/0008-5472.BCD-19-0039 |
0.323 |
|
| 2020 |
De Dominici M, Porazzi P, Xiao Y, Chao A, Tang HY, Kumar G, Fortina P, Spinelli O, Rambaldi A, Peterson LF, Petruk S, Barletta C, Mazo A, Cingolani G, Salvino JM, ... Calabretta B, et al. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and independent effects by CDK6-specific PROTACs. Blood. PMID 32040545 DOI: 10.1182/Blood.2019003604 |
0.427 |
|
| 2020 |
Spagnuolo M, Regazzo G, Sacconi A, Méndez ABD, Calabretta B, Rizzo MG. Abstract 2538: Investigating the role of the oncogenic miR-17-92 cluster as involved in TKI-resistance enhancing the survival of MYB-dependent Ph+ acute lymphoblastic leukemia cells Cancer Research. 80: 2538-2538. DOI: 10.1158/1538-7445.Am2020-2538 |
0.352 |
|
| 2019 |
Kasner MT, Wilde L, Keiffer G, Palmisiano ND, Calabretta B. A phase I trial of palbociclib in combination with dexamethasone in relapsed or refractory adult B-cell acute lymphoblastic leukemia (ALL). Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps7065 |
0.492 |
|
| 2019 |
Silvestri G, Trotta R, Stramucci L, Wang S, Eisfeld A, Zhang B, Srutova K, Pineda G, Jamieson C, Stagno F, Vigneri P, Nteliopoulos G, Guimond M, Hokland P, Deininger MW, ... ... Calabretta B, et al. A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity Blood. 134: 4141-4141. DOI: 10.1182/Blood-2019-131113 |
0.406 |
|
| 2018 |
Minieri V, De Dominici M, Porazzi P, Mariani SA, Spinelli O, Rambaldi A, Peterson LF, Porcu P, Nevalainen MT, Calabretta B. Targeting STAT5 or STAT5-regulated pathways suppresses leukemogenesis of Ph+ acute lymphoblastic leukemia. Cancer Research. PMID 30154155 DOI: 10.1158/0008-5472.Can-18-0195 |
0.431 |
|
| 2018 |
Spagnuolo M, Regazzo G, De Dominici M, Sacconi A, Pelosi A, Korita E, Marchesi F, Pisani F, Magenta A, Lulli V, Cordone I, Mengarelli A, Strano S, Blandino G, Rizzo MG, ... Calabretta B, et al. Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells. Haematologica. PMID 30076175 DOI: 10.3324/Haematol.2018.191213 |
0.45 |
|
| 2018 |
Barbieri E, Trizzino M, Welsh SA, Owens TA, Calabretta B, Carroll M, Sarma K, Gardini A. Targeted Enhancer Activation by a Subunit of the Integrator Complex. Molecular Cell. 71: 103-116.e7. PMID 30008316 DOI: 10.1016/J.Molcel.2018.05.031 |
0.378 |
|
| 2018 |
Parenti S, Montorsi L, Fantini S, Mammoli F, Gemelli C, Atene CG, Losi L, Frassineti C, Calabretta B, Tagliafico E, Ferrari S, Zanocco-Marani T, Grande A. KLF4 mediates the effect of 5-ASA on the β-catenin pathway in colon cancer cells. Cancer Prevention Research (Philadelphia, Pa.). PMID 29794245 DOI: 10.1158/1940-6207.Capr-17-0382 |
0.361 |
|
| 2018 |
Silvestri G, Stramucci L, Ellis J, Harb J, Neviani P, Zhang B, Srutova K, Pineda G, Jamieson C, Calabretta B, Stagno F, Vigneri P, Nteliopoulos G, May P, Reid A, et al. Abstract 1134: The tumor suppressor activity of miR-300 is detrimental for leukemia development but required for leukemia stem cell maintenance Cancer Research. 78: 1134-1134. DOI: 10.1158/1538-7445.Am2018-1134 |
0.337 |
|
| 2017 |
De Dominici M, Porazzi P, Soliera AR, Mariani SA, Addya S, Fortina P, Peterson LF, Spinelli O, Rambaldi A, Martinelli G, Ferrari A, Iacobucci I, Calabretta B. Targeting CDK6 and BCL2 exploits the "MYB addiction" of Ph+ acute lymphoblastic leukemia. Cancer Research. PMID 29233926 DOI: 10.1158/0008-5472.Can-17-2644 |
0.411 |
|
| 2017 |
Petruk S, Cai J, Sussman R, Sun G, Kovermann SK, Mariani SA, Calabretta B, McMahon SB, Brock HW, Iacovitti L, Mazo A. Delayed Accumulation of H3K27me3 on Nascent DNA Is Essential for Recruitment of Transcription Factors at Early Stages of Stem Cell Differentiation. Molecular Cell. PMID 28410996 DOI: 10.1016/J.Molcel.2017.03.006 |
0.402 |
|
| 2017 |
Petruk S, Mariani SA, De Dominici M, Porazzi P, Minieri V, Cai J, Iacovitti L, Flomenberg N, Calabretta B, Mazo A. Structure of Nascent Chromatin Is Essential for Hematopoietic Lineage Specification. Cell Reports. 19: 295-306. PMID 28402853 DOI: 10.1016/J.Celrep.2017.03.035 |
0.325 |
|
| 2016 |
Riva B, Dominici M, Gnemmi I, Mariani SA, Minassi A, Minieri V, Salomoni P, Canonico PL, Genazzani AA, Calabretta B, Condorelli F. Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2. Oncotarget. PMID 27835591 DOI: 10.18632/Oncotarget.13146 |
0.442 |
|
| 2016 |
Montorsi L, Parenti S, Losi L, Ferrarini F, Gemelli C, Rossi A, Manco G, Ferrari S, Calabretta B, Tagliafico E, Zanocco-Marani T, Grande A. Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes. Cell Death & Disease. 7: e2263. PMID 27310872 DOI: 10.1038/Cddis.2016.163 |
0.326 |
|
| 2016 |
Karvela M, Baquero P, Kuntz EM, Mukhopadhyay A, Mitchell R, Allan EK, Chan E, Kranc KR, Calabretta B, Salomoni P, Gottlieb E, Holyoake TL, Helgason GV. ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells. Autophagy. 1-13. PMID 27168493 DOI: 10.1080/15548627.2016.1162359 |
0.414 |
|
| 2016 |
Mariani SA, Minieri V, De Dominici M, Iacobucci I, Peterson LF, Calabretta B. CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia. Leukemia. PMID 27125204 DOI: 10.1038/Leu.2016.70 |
0.453 |
|
| 2016 |
Yu J, Silvestri G, Stramucci L, Sanada M, Yamaguchi T, Du Y, Westermarck J, Caligiuri MA, Garzon R, Milojkovic D, Apperley JF, Roy D, Marcucci G, Calabretta B, Baer MR, et al. Potential Targeting Ph+ Acute Lymphoblastic Leukemia Stem and Progenitor Cells By Modulating the CIP2A-SET-SETBP1 -Mediated Suppression of PP2A Activity Blood. 128: 2909-2909. DOI: 10.1182/Blood.V128.22.2909.2909 |
0.399 |
|
| 2015 |
Manzotti G, Parenti S, Ferrari-Amorotti G, Soliera AR, Cattelani S, Montanari M, Cavalli D, Ertel A, Grande A, Calabretta B. Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database. Cell Cycle (Georgetown, Tex.). 14: 2578-89. PMID 26102293 DOI: 10.1080/15384101.2015.1033591 |
0.528 |
|
| 2015 |
Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, ... ... Calabretta B, et al. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. Molecular Cancer Therapeutics. PMID 26026053 DOI: 10.1158/1535-7163.Mct-14-0883 |
0.35 |
|
| 2014 |
Ferrari-Amorotti G, Chiodoni C, Shen F, Cattelani S, Soliera AR, Manzotti G, Grisendi G, Dominici M, Rivasi F, Colombo MP, Fatatis A, Calabretta B. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity. Neoplasia (New York, N.Y.). 16: 1047-58. PMID 25499218 DOI: 10.1016/J.Neo.2014.10.006 |
0.377 |
|
| 2014 |
Mariani SA, Calabretta B. Leukemia stem cells: Old concepts and new perspectives. Molecular Aspects of Medicine. 39: 102-9. PMID 23820118 DOI: 10.1016/J.Mam.2013.06.003 |
0.407 |
|
| 2013 |
Helgason GV, Mukhopadhyay A, Karvela M, Salomoni P, Calabretta B, Holyoake TL. Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy. Current Cancer Drug Targets. 13: 724-34. PMID 23941517 DOI: 10.2174/15680096113139990088 |
0.418 |
|
| 2013 |
Ferrari-Amorotti G, Fragliasso V, Esteki R, Prudente Z, Soliera AR, Cattelani S, Manzotti G, Grisendi G, Dominici M, Pieraccioli M, Raschellà G, Chiodoni C, Colombo MP, Calabretta B. Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion. Cancer Research. 73: 235-45. PMID 23054398 DOI: 10.1158/0008-5472.Can-12-1739 |
0.434 |
|
| 2013 |
Pelosi A, Careccia S, Lulli V, Romania P, Marziali G, Testa U, Lavorgna S, Lo-Coco F, Petti MC, Calabretta B, Levrero M, Piaggio G, Rizzo MG. miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia Oncogene. 32: 3648-3654. PMID 22964640 DOI: 10.1038/Onc.2012.398 |
0.434 |
|
| 2012 |
Manzotti G, Mariani S, Corradini F, Bussolari R, Cesi V, Vergalli J, Ferrari-Amorotti G, Fragliasso V, Soliera AR, Cattelani S, Raschella G, Holyoake TL, Calabretta B. Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. Blood Cancer Journal. 2: 1-11. PMID 22829973 DOI: 10.1038/Bcj.2012.16 |
0.55 |
|
| 2012 |
Soliera AR, Mariani SA, Audia A, Lidonnici MR, Addya S, Ferrari-Amorotti G, Cattelani S, Manzotti G, Fragliasso V, Peterson L, Perini G, Holyoake TL, Calabretta B. Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1. Leukemia. 26: 1555-1563. PMID 22285998 DOI: 10.1038/Leu.2012.19 |
0.552 |
|
| 2012 |
Fragliasso V, Chiodo Y, Ferrari-Amorotti G, Soliera AR, Manzotti G, Cattelani S, Candini O, Grisendi G, Vergalli J, Mariani SA, Guerzoni C, Calabretta B. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. Journal of Cellular Biochemistry. 113: 1704-13. PMID 22212957 DOI: 10.1002/Jcb.24040 |
0.504 |
|
| 2012 |
Calabretta B, Salomoni P. Suppression of autophagy by BCR/ABL. Frontiers in Bioscience (Scholar Edition). 4: 453-60. PMID 22202070 DOI: 10.2741/278 |
0.444 |
|
| 2012 |
Waldron T, De Dominici M, Soliera AR, Audia A, Iacobucci I, Lonetti A, Martinelli G, Zhang Y, Martinez R, Hyslop T, Bender TP, Calabretta B. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia. 26: 644-53. PMID 21960247 DOI: 10.1038/Leu.2011.264 |
0.811 |
|
| 2012 |
Helgason G, Allan EK, Mariani S, Mukhopadhyay A, Karvela M, Galavotti S, Audia A, Hamilton A, Nicolini FE, Druker BJ, Salomoni P, Calabretta B, Holyoake TL. Inhibition of Autophagy in Combination with Ponatinib or Dual PI3K/mTOR Inhibition to Improve Treatment Response for Both Bcr-Abl Dependent and Independent Mechanisms of TKI-Resistance in CML Blood. 120: 1664-1664. DOI: 10.1182/Blood.V120.21.1664.1664 |
0.43 |
|
| 2011 |
Cesi V, Casciati A, Sesti F, Tanno B, Calabretta B, Raschellà G. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. Cell Cycle (Georgetown, Tex.). 10: 4149-61. PMID 22101269 DOI: 10.4161/Cc.10.23.18346 |
0.464 |
|
| 2011 |
Calabretta B, Salomoni P. Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. Leukemia & Lymphoma. 52: 54-9. PMID 21250825 DOI: 10.3109/10428194.2010.546913 |
0.434 |
|
| 2011 |
La Rocca G, Shi B, Audia A, Ferrari-Amorotti G, Mellert HS, Calabretta B, McMahon SB, Sepp-Lorenzino L, Baserga R. Regulation of microRNA-145 by growth arrest and differentiation. Experimental Cell Research. 317: 488-95. PMID 21111732 DOI: 10.1016/J.Yexcr.2010.11.010 |
0.341 |
|
| 2010 |
Lidonnici MR, Audia A, Soliera AR, Prisco M, Ferrari-Amorotti G, Waldron T, Donato N, Zhang Y, Martinez RV, Holyoake TL, Calabretta B. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells. Cancer Research. 70: 7949-59. PMID 20924107 DOI: 10.1158/0008-5472.Can-10-1667 |
0.818 |
|
| 2010 |
Ferrari-Amorotti G, Mariani SA, Novi C, Cattelani S, Pecorari L, Corradini F, Soliera AR, Manzotti G, Fragliasso V, Zhang Y, Martinez RV, Lam EW, Guerzoni C, Calabretta B. The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain. The Journal of Biological Chemistry. 285: 30837-50. PMID 20659895 DOI: 10.1074/Jbc.M110.128272 |
0.499 |
|
| 2010 |
Tanno B, Sesti F, Cesi V, Bossi G, Ferrari-Amorotti G, Bussolari R, Tirindelli D, Calabretta B, Raschellà G. Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. The Journal of Biological Chemistry. 285: 29434-45. PMID 20622260 DOI: 10.1074/Jbc.M109.089045 |
0.535 |
|
| 2010 |
Waldron TJ, Soliera AR, Zhang Y, Martinez R, Hyslop T, Bender T, Calabretta B. Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1 Cancer Research. 70: 5061-5061. DOI: 10.1158/1538-7445.Am10-5061 |
0.799 |
|
| 2009 |
Salomoni P, Calabretta B. Targeted therapies and autophagy: new insights from chronic myeloid leukemia. Autophagy. 5: 1050-1. PMID 19713759 DOI: 10.4161/Auto.5.7.9509 |
0.459 |
|
| 2009 |
Pecorari L, Marin O, Silvestri C, Candini O, Rossi E, Guerzoni C, Cattelani S, Mariani SA, Corradini F, Ferrari-Amorotti G, Cortesi L, Bussolari R, Raschellà G, Federico MR, Calabretta B. Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility. Molecular Cancer. 8: 58. PMID 19646290 DOI: 10.1186/1476-4598-8-58 |
0.362 |
|
| 2009 |
Vitali R, Mancini C, Cesi V, Tanno B, Piscitelli M, Mancuso M, Sesti F, Pasquali E, Calabretta B, Dominici C, Raschellà G. Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model. International Journal of Cancer. Journal International Du Cancer. 125: 2547-55. PMID 19623650 DOI: 10.1002/Ijc.24606 |
0.446 |
|
| 2009 |
Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, Yacobi R, Van Etten RA, Donato N, Hunter A, Dinsdale D, Tirrò E, ... ... Calabretta B, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. The Journal of Clinical Investigation. 119: 1109-23. PMID 19363292 DOI: 10.1172/Jci35660 |
0.459 |
|
| 2008 |
Vitali R, Mancini C, Cesi V, Tanno B, Mancuso M, Bossi G, Zhang Y, Martinez RV, Calabretta B, Dominici C, Raschellà G. Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4622-30. PMID 18628477 DOI: 10.1158/1078-0432.Ccr-07-5210 |
0.489 |
|
| 2008 |
Soliera AR, Lidonnici MR, Ferrari-Amorotti G, Prisco M, Zhang Y, Martinez RV, Donato NJ, Calabretta B. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells. Blood. 112: 1942-50. PMID 18550858 DOI: 10.1182/Blood-2007-09-114975 |
0.538 |
|
| 2008 |
Vitali R, Cesi V, Tanno B, Ferrari-Amorotti G, Dominici C, Calabretta B, Raschellà G. Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide. Biochemical and Biophysical Research Communications. 368: 350-6. PMID 18230339 DOI: 10.1016/J.Bbrc.2008.01.093 |
0.318 |
|
| 2008 |
Lidonnici MR, Corradini F, Waldron T, Bender TP, Calabretta B. Requirement of c-Myb for p210 BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis Blood. 111: 4771-4779. PMID 18227349 DOI: 10.1182/Blood-2007-08-105072 |
0.8 |
|
| 2008 |
Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, Etten RAV, Donato N, Hunter A, Dinsdale D, Tirro E, Vigneri P, ... ... Calabretta B, et al. Targeting Autophagy Potentiates Imatinib-Induced Cell Death in Philadelphia Positive Cells Including Primary CML Stem Cells. Blood. 112: 1070-1070. DOI: 10.1182/Blood.V112.11.1070.1070 |
0.499 |
|
| 2007 |
Corradini F, Bussolari R, Cerioli D, Lidonnici MR, Calabretta B. A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells. Blood Cells, Molecules & Diseases. 39: 292-6. PMID 17644012 DOI: 10.1016/J.Bcmd.2007.06.002 |
0.541 |
|
| 2007 |
Chang JS, Santhanam R, Trotta R, Neviani P, Eiring AM, Briercheck E, Ronchetti M, Roy DC, Calabretta B, Caligiuri MA, Perrotti D. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood. 110: 994-1003. PMID 17475908 DOI: 10.1182/Blood-2007-03-078303 |
0.487 |
|
| 2007 |
Iotti G, Ferrari-Amorotti G, Rosafio C, Corradini F, Lidonnici MR, Ronchetti M, Bardini M, Zhang Y, Martinez R, Blasi F, Calabretta B. Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells. Oncogene. 26: 3482-3491. PMID 17160016 DOI: 10.1038/Sj.Onc.1210146 |
0.567 |
|
| 2007 |
Liu M, Tu X, Ferrari-Amorotti G, Calabretta B, Baserga R. Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate. Journal of Cellular Biochemistry. 100: 1154-69. PMID 17063482 DOI: 10.1002/Jcb.21103 |
0.48 |
|
| 2007 |
Bussolari R, Candini O, Colomer D, Corradini F, Guerzoni C, Mariani SA, Cattelani S, Silvestri C, Pecorari L, Iacobucci I, Soverini S, Fasano T, Martinelli G, Cervantes F, Calabretta B. Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients. Leukemia Research. 31: 163-7. PMID 16797705 DOI: 10.1016/J.Leukres.2006.05.007 |
0.495 |
|
| 2006 |
Guerzoni C, Ferrari-Amorotti G, Bardini M, Mariani SA, Calabretta B. Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-expressing cells: differences and similarities. Cell Cycle (Georgetown, Tex.). 5: 1254-7. PMID 16760662 DOI: 10.4161/Cc.5.12.2808 |
0.502 |
|
| 2006 |
Ferrari-Amorotti G, Keeshan K, Zattoni M, Guerzoni C, Iotti G, Cattelani S, Donato NJ, Calabretta B. Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha. Blood. 108: 1353-62. PMID 16670262 DOI: 10.1182/Blood-2006-01-011833 |
0.491 |
|
| 2006 |
Guerzoni C, Bardini M, Mariani SA, Ferrari-Amorotti G, Neviani P, Panno ML, Zhang Y, Martinez R, Perrotti D, Calabretta B. Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells. Blood. 107: 4080-9. PMID 16418324 DOI: 10.1182/Blood-2005-08-3181 |
0.56 |
|
| 2005 |
Corradini F, Cesi V, Bartella V, Pani E, Bussolari R, Candini O, Calabretta B. Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants. The Journal of Biological Chemistry. 280: 30254-62. PMID 15927960 DOI: 10.1074/Jbc.M504703200 |
0.534 |
|
| 2005 |
Cesi V, Giuffrida ML, Vitali R, Tanno B, Mancini C, Calabretta B, Raschellà G. C/EBP alpha and beta mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site. Experimental Cell Research. 305: 179-89. PMID 15777798 DOI: 10.1016/J.Yexcr.2004.12.015 |
0.434 |
|
| 2005 |
Tanno B, Cesi V, Vitali R, Sesti F, Giuffrida ML, Mancini C, Calabretta B, Raschellà G. Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells. Cell Death and Differentiation. 12: 213-23. PMID 15618969 DOI: 10.1038/Sj.Cdd.4401546 |
0.439 |
|
| 2004 |
Prisco M, Maiorana A, Guerzoni C, Calin G, Calabretta B, Voit R, Grummt I, Baserga R. Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells. Molecular and Cellular Biology. 24: 5421-33. PMID 15169904 DOI: 10.1128/Mcb.24.12.5421-5433.2004 |
0.443 |
|
| 2004 |
Perrotti D, Calabretta B. Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene. 23: 3222-9. PMID 15094772 DOI: 10.1038/Sj.Onc.1207543 |
0.4 |
|
| 2004 |
Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 103: 4010-22. PMID 14982876 DOI: 10.1182/Blood-2003-12-4111 |
0.479 |
|
| 2004 |
Zenz T, Roessner A, Thomas A, Frohling S, Döhner H, Calabretta B, Daheron L. hIan5: the human ortholog to the rat Ian4/Iddm1/lyp is a new member of the Ian family that is overexpressed in B-cell lymphoid malignancies. Genes and Immunity. 5: 109-116. PMID 14724691 DOI: 10.1038/Sj.Gene.6364044 |
0.38 |
|
| 2003 |
Keeshan K, Santilli G, Corradini F, Perrotti D, Calabretta B. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Blood. 102: 1267-75. PMID 12702500 DOI: 10.1182/Blood-2003-02-0477 |
0.496 |
|
| 2003 |
Trotta R, Vignudelli T, Candini O, Intine RV, Pecorari L, Guerzoni C, Santilli G, Byrom MW, Goldoni S, Ford LP, Caligiuri MA, Maraia RJ, Perrotti D, Calabretta B. BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell. 3: 145-60. PMID 12620409 DOI: 10.1016/S1535-6108(03)00020-5 |
0.466 |
|
| 2002 |
Perrotti D, Calabretta B. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene. 21: 8577-83. PMID 12476304 DOI: 10.1038/Sj.Onc.1206085 |
0.402 |
|
| 2002 |
Cesi V, Tanno B, Vitali R, Mancini C, Giuffrida ML, Calabretta B, Raschellà G. Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation. Cell Death and Differentiation. 9: 1232-9. PMID 12404122 DOI: 10.1038/Sj.Cdd.4401103 |
0.418 |
|
| 2002 |
Rosen K, Shi W, Calabretta B, Filmus J. Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. The Journal of Biological Chemistry. 277: 46123-30. PMID 12356751 DOI: 10.1074/Jbc.M207883200 |
0.466 |
|
| 2002 |
Tanno B, Negroni A, Vitali R, Pirozzoli MC, Cesi V, Mancini C, Calabretta B, Raschellà G. Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms. The Journal of Biological Chemistry. 277: 23172-80. PMID 11973331 DOI: 10.1074/Jbc.M200141200 |
0.422 |
|
| 2002 |
Iervolino A, Santilli G, Trotta R, Guerzoni C, Cesi V, Bergamaschi A, Gambacorti-Passerini C, Calabretta B, Perrotti D. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis. Molecular and Cellular Biology. 22: 2255-66. PMID 11884611 DOI: 10.1128/Mcb.22.7.2255-2266.2002 |
0.462 |
|
| 2002 |
Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA, Calabretta B. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nature Genetics. 30: 48-58. PMID 11753385 DOI: 10.1038/Ng791 |
0.536 |
|
| 2001 |
Amendola R, Martinez R, Negroni A, Venturelli D, Tanno B, Calabretta B, Raschellà G. DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics. Medical and Pediatric Oncology. 36: 93-96. PMID 11464913 DOI: 10.1002/1096-911X(20010101)36:1<93::Aid-Mpo1021>3.0.Co;2-3 |
0.449 |
|
| 2001 |
Powzaniuk MA, Trotta R, Loza MJ, Harth A, Iozzo RV, Eisenlohr LC, Perussia B, Calabretta B. B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells. Journal of Immunology (Baltimore, Md. : 1950). 167: 242-9. PMID 11418655 DOI: 10.4049/Jimmunol.167.1.242 |
0.462 |
|
| 2001 |
Biroccio A, Benassi B, D’Agnano I, D’Angelo C, Buglioni S, Mottolese M, Ricciotti A, Citro G, Cosimelli M, Ramsay RG, Calabretta B, Zupi G. c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. American Journal of Pathology. 158: 1289-1299. PMID 11290547 DOI: 10.1016/S0002-9440(10)64080-1 |
0.446 |
|
| 2001 |
Condorelli F, Salomoni P, Cotteret S, Cesi V, Srinivasula SM, Alnemri ES, Calabretta B. Caspase cleavage enhances the apoptosis-inducing effects of BAD. Molecular and Cellular Biology. 21: 3025-36. PMID 11287608 DOI: 10.1128/Mcb.21.9.3025-3036.2001 |
0.348 |
|
| 2001 |
Dahéron L, Zenz T, Siracusa LD, Brenner C, Calabretta B. Molecular cloning of Ian4: A BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activity Nucleic Acids Research. 29: 1308-1316. PMID 11238997 DOI: 10.1093/Nar/29.6.1308 |
0.361 |
|
| 2000 |
Pagnan G, Stuart DD, Pastorino F, Raffaghello L, Montaldo PG, Allen TM, Calabretta B, Ponzoni M. Delivery of c-myb Antisense Oligodeoxynucleotides to Human Neuroblastoma Cells Via Disialoganglioside GD2-Targeted Immunoliposomes: Antitumor Effects. Journal of the National Cancer Institute. 92: 253-261. PMID 28158676 DOI: 10.1093/jnci/92.3.253 |
0.312 |
|
| 2000 |
Negroni A, Venturelli D, Tanno B, Amendola R, Ransac S, Cesi V, Calabretta B, Raschellà G. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Cell Death & Differentiation. 7: 843-850. PMID 11042679 DOI: 10.1038/Sj.Cdd.4400720 |
0.376 |
|
| 2000 |
Fernandes MJ, Iscove NN, Gingras G, Calabretta B. Identification and characterization of the gene for a novel C-type lectin (CLECSF7) that maps near the natural killer gene complex on human chromosome 12. Genomics. 69: 263-70. PMID 11031109 DOI: 10.1006/Geno.2000.6316 |
0.392 |
|
| 2000 |
Perrotti D, Iervolino A, Cesi V, Cirinná M, Lombardini S, Grassilli E, Bonatti S, Claudio PP, Calabretta B. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway. Molecular and Cellular Biology. 20: 6159-69. PMID 10913197 DOI: 10.1128/Mcb.20.16.6159-6169.2000 |
0.512 |
|
| 2000 |
Venturelli D, Cesi V, Ransac S, Engelhard A, Perrotti D, Calabretta B. The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells. Experimental Cell Research. 257: 265-71. PMID 10837140 DOI: 10.1006/Excr.2000.4899 |
0.373 |
|
| 2000 |
Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C, Sevignani C, Calabretta B, Sala A. Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. Journal of Biological Chemistry. 275: 21055-21060. PMID 10770937 DOI: 10.1074/Jbc.M002055200 |
0.474 |
|
| 2000 |
Manzella L, Gualdi R, Perrotti D, Nicolaides NC, Girlando G, Giuffrida MA, Messina A, Calabretta B. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: Possible role in the regulation of c-myb expression Experimental Cell Research. 256: 248-256. PMID 10739671 DOI: 10.1006/Excr.1999.4794 |
0.504 |
|
| 2000 |
De Falco G, Bagella L, Claudio PP, De Luca A, Fu Y, Calabretta B, Sala A, Giordano A. Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation. Oncogene. 19: 373-9. PMID 10656684 DOI: 10.1038/Sj.Onc.1203305 |
0.403 |
|
| 2000 |
Pagnan G, Stuart DD, Pastorino F, Raffaghello L, Montaldo PG, Allen TM, Calabretta B, Ponzoni M. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects. Journal of the National Cancer Institute. 92: 253-61. PMID 10655443 DOI: 10.1093/Jnci/92.3.253 |
0.487 |
|
| 2000 |
Engelhard A, Campbell K, Calabretta B. B-myb Alters the Response of Myeloid Precursor Cells to G-CSF Experimental Cell Research. 254: 153-162. PMID 10623475 DOI: 10.1006/Excr.1999.4742 |
0.491 |
|
| 2000 |
Salomoni P, Condorelli F, Sweeney SM, Calabretta B. Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects Blood. 96: 676-684. DOI: 10.1182/Blood.V96.2.676.014K25_676_684 |
0.484 |
|
| 2000 |
Cirinnà M, Trotta R, Salomoni P, Kossev P, Wasik M, Perrotti D, Calabretta B. Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation Blood. 96: 3915-3921. DOI: 10.1182/Blood.V96.12.3915.H8003915_3915_3921 |
0.49 |
|
| 1999 |
Putney SD, Brown J, Cucco C, Lee R, Skorski T, Leonetti C, Geiser T, Calabretta B, Zupi G, Zon G. Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide. Antisense & Nucleic Acid Drug Development. 9: 451-8. PMID 10555152 DOI: 10.1089/Oli.1.1999.9.451 |
0.379 |
|
| 1999 |
Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Molecular and Cellular Biology. 19: 7203-7215. PMID 10490655 DOI: 10.1128/Mcb.19.10.7203 |
0.345 |
|
| 1999 |
Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. The Journal of Experimental Medicine. 189: 1229-42. PMID 10209040 DOI: 10.1084/Jem.189.8.1229 |
0.464 |
|
| 1999 |
Iozzo RV, Chakrani F, Perrotti D, McQuillan DJ, Skorski T, Calabretta B, Eichstetter I. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 96: 3092-7. PMID 10077642 DOI: 10.1073/Pnas.96.6.3092 |
0.412 |
|
| 1998 |
Raschellà G, Tanno B, Bonetto F, Negroni A, Claudio PP, Baldi A, Amendola R, Calabretta B, Giordano A, Paggi MG. The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation. Cell Death and Differentiation. 5: 401-7. PMID 10200489 DOI: 10.1038/Sj.Cdd.4400359 |
0.456 |
|
| 1998 |
Skorski T, Wlodarski P, Daheron L, Salomoni P, Nieborowska-Skorska M, Majewski M, Wasik M, Calabretta B. BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac Proceedings of the National Academy of Sciences of the United States of America. 95: 11858-11862. PMID 9751755 DOI: 10.1073/Pnas.95.20.11858 |
0.507 |
|
| 1998 |
Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. The Embo Journal. 17: 4442-55. PMID 9687511 DOI: 10.1093/Emboj/17.15.4442 |
0.475 |
|
| 1998 |
Salomoni P, Wasik MA, Riedel RF, Reiss K, Choi JK, Skorski T, Calabretta B. Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant. The Journal of Experimental Medicine. 187: 1995-2007. PMID 9625759 DOI: 10.1084/Jem.187.12.1995 |
0.486 |
|
| 1998 |
Sevignani C, Wlodarski P, Kirillova J, Mercer WE, Danielson KG, Iozzo RV, Calabretta B. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene. The Journal of Clinical Investigation. 101: 1572-80. PMID 9541486 DOI: 10.1172/Jci919 |
0.405 |
|
| 1998 |
Fabritiis Pd, Petti MC, Montefusco E, Propris MSD, Sala R, Bellucci R, Mancini M, Lisci A, Bonetto F, Geiser T, Calabretta B, Mandelli F. BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase Blood. 91: 3156-3162. DOI: 10.1182/Blood.V91.9.3156.3156_3156_3162 |
0.363 |
|
| 1998 |
Wlodarski P, Wasik M, Ratajczak MZ, Sevignani C, Hoser G, Kawiak J, Gewirtz AM, Calabretta B, Skorski T. Role of p53 in Hematopoietic Recovery After Cytotoxic Treatment Blood. 91: 2998-3006. DOI: 10.1182/Blood.V91.8.2998.2998_2998_3006 |
0.423 |
|
| 1998 |
Ratajczak MZ, Perrotti D, Melotti P, Powzaniuk M, Calabretta B, Onodera K, Kregenow DA, Machalinski B, Gewirtz AM. Myb and Ets Proteins Are Candidate Regulators of c-kit Expression in Human Hematopoietic Cells Blood. 91: 1934-1946. DOI: 10.1182/Blood.V91.6.1934.1934_1934_1946 |
0.48 |
|
| 1998 |
Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B, Calabretta B. The SH3 Domain Contributes to BCR/ABL-Dependent Leukemogenesis In Vivo: Role in Adhesion, Invasion, and Homing Blood. 91: 406-418. DOI: 10.1182/Blood.V91.2.406.406_406_418 |
0.49 |
|
| 1997 |
Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway Embo Journal. 16: 6151-6161. PMID 9321394 DOI: 10.1093/Emboj/16.20.6151 |
0.44 |
|
| 1997 |
Amendola R, Martinez R, Negroni A, Venturelli D, Tanno B, Calabretta B, Raschella G. DR-nm23 Gene Expression in Neuroblastoma Cells: Relationship to Integrin Expression, Adhesion Characteristics, and Differentiation Journal of the National Cancer Institute. 89: 1300-1310. PMID 9293921 DOI: 10.1093/Jnci/89.17.1300 |
0.46 |
|
| 1997 |
Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. The Journal of Clinical Investigation. 100: 149-57. PMID 9202067 DOI: 10.1172/Jci119507 |
0.47 |
|
| 1997 |
de Fabritiis P, Skorski T, De Propris MS, Paggi MG, Nieborowska-Skorska M, Lisci A, Buffolino S, Campbell K, Geiser T, Calabretta B. Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells. Leukemia. 11: 811-9. PMID 9177433 DOI: 10.1038/Sj.Leu.2400664 |
0.415 |
|
| 1997 |
Skorski T, Perrotti D, Nieborowska-Skorska M, Gryaznov S, Calabretta B. Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo. Proceedings of the National Academy of Sciences of the United States of America. 94: 3966-71. PMID 9108088 DOI: 10.1073/Pnas.94.8.3966 |
0.406 |
|
| 1997 |
Salomoni P, Perrotti D, Martinez R, Franceschi C, Calabretta B. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proceedings of the National Academy of Sciences of the United States of America. 94: 3296-301. PMID 9096387 DOI: 10.1073/Pnas.94.7.3296 |
0.526 |
|
| 1997 |
DeRocco SE, Iozzo R, Ma XP, Schwarting R, Peterson D, Calabretta B. Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. Proceedings of the National Academy of Sciences of the United States of America. 94: 3240-4. PMID 9096377 DOI: 10.1073/Pnas.94.7.3240 |
0.433 |
|
| 1997 |
Scarpa S, Negroni A, Amendola R, Signorelli P, Calabretta B, Modesti A, Raschella G. Phenotypic and morphological characterization of neuroblastoma cells constitutively expressing B-myb Journal of Neuro-Oncology. 31: 107-114. PMID 9049836 DOI: 10.1023/A:1005749802210 |
0.447 |
|
| 1997 |
Calabretta B, Skorski T. Gene regulatory mechanisms operative on hematopoietic cells: proliferation, differentiation, and neoplasia. Critical Reviews in Eukaryotic Gene Expression. 7: 117-24. PMID 9034718 DOI: 10.1615/Critreveukargeneexpr.V7.I1-2.70 |
0.447 |
|
| 1997 |
Calabretta B, Skorski T. BCR/ABL regulation of PI-3 kinase activity. Leukemia & Lymphoma. 23: 473-6. PMID 9031078 DOI: 10.3109/10428199609054856 |
0.363 |
|
| 1997 |
Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K, Peschle C. Activation of human B-MYB by cyclins. Proceedings of the National Academy of Sciences of the United States of America. 94: 532-6. PMID 9012818 DOI: 10.1073/Pnas.94.2.532 |
0.446 |
|
| 1997 |
Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Hoser G, Kawiak J, Majewski M, Christensen L, Iozzo RV, Calabretta B. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides. Journal of the National Cancer Institute. 89: 124-33. PMID 8998181 DOI: 10.1093/Jnci/89.2.124 |
0.435 |
|
| 1997 |
Bellon T, Perrotti D, Calabretta B. Granulocytic Differentiation of Normal Hematopoietic Precursor Cells Induced by Transcription Factor PU.1 Correlates With Negative Regulation of the c-myb Promoter Blood. 90: 1828-1839. DOI: 10.1182/Blood.V90.5.1828 |
0.568 |
|
| 1997 |
Sorio C, Melotti P, D'Arcangelo D, Mendrola J, Calabretta B, Croce CM, Huebner K. Receptor Protein Tyrosine Phosphatase Gamma, Ptpγ, Regulates Hematopoietic Differentiation Blood. 90: 49-57. DOI: 10.1182/Blood.V90.1.49.49_49_57 |
0.476 |
|
| 1997 |
Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases Matrix Biology. 16: 121. DOI: 10.1016/S0945-053X(97)90047-0 |
0.417 |
|
| 1996 |
Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Martinez R, Wasik MA, Calabretta B. Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase. Proceedings of the National Academy of Sciences of the United States of America. 93: 13137-42. PMID 8917557 DOI: 10.1073/Pnas.93.23.13137 |
0.434 |
|
| 1996 |
Ratajczak MZ, Ratajczak J, Skorska M, Marlicz W, Calabretta B, Pletcher CH, Moore J, Gewirtz AM. Effect of basic (FGF-2) and acidic (FGF-1) fibroblast growth factors on early haemopoietic cell development British Journal of Haematology. 93: 772-782. PMID 8703802 DOI: 10.1046/J.1365-2141.1996.D01-1736.X |
0.441 |
|
| 1996 |
Del Bufalo D, Cucco C, Leonetti C, Citro G, D'Agnano I, Benassi M, Geiser T, Zon G, Calabretta B, Zupi G. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo. British Journal of Cancer. 74: 387-93. PMID 8695353 DOI: 10.1038/Bjc.1996.370 |
0.48 |
|
| 1996 |
Melotti P, Calabretta B. The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America. 93: 5313-5318. PMID 8643572 DOI: 10.1073/Pnas.93.11.5313 |
0.516 |
|
| 1996 |
Gryaznov S, Skorski T, Cucco C, Nieborowska-Skorska M, Chiu CY, Lloyd D, Chen JK, Koziolkiewicz M, Calabretta B. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. Nucleic Acids Research. 24: 1508-14. PMID 8628685 DOI: 10.1093/Nar/24.8.1508 |
0.458 |
|
| 1996 |
Sala A, Casella I, Bellon T, Calabretta B, Watson RJ, Peschle C. B-myb Promotes S Phase and Is a Downstream Target of the Negative Regulator p107 in Human Cells Journal of Biological Chemistry. 271: 9363-9367. PMID 8621601 DOI: 10.1074/Jbc.271.16.9363 |
0.459 |
|
| 1996 |
Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. Journal of the National Cancer Institute. 88: 419-29. PMID 8618233 DOI: 10.1093/Jnci/88.7.419 |
0.382 |
|
| 1996 |
Raschellà G, Negroni A, Pucci S, Amendola R, Valeri S, Calabretta B. B-myb Transcriptional Regulation and mRNA Stability during Differentiation of Neuroblastoma Cells Experimental Cell Research. 222: 395-399. PMID 8598228 DOI: 10.1006/Excr.1996.0049 |
0.467 |
|
| 1996 |
Skorski T, Nieborowska-Skorska M, Campbell K, Iozzo RV, Zon G, Darzynkiewicz Z, Calabretta B. Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. The Journal of Experimental Medicine. 182: 1645-53. PMID 7500009 DOI: 10.1084/Jem.182.6.1645 |
0.448 |
|
| 1996 |
Perrotti D, Bellon T, Trotta R, Martinez R, Calabretta B. A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element Blood. 88: 3336-3348. DOI: 10.1182/Blood.V88.9.3336.Bloodjournal8893336 |
0.402 |
|
| 1996 |
Skorski T, Nieborowska-Skorska M, Wlodarski P, Zon G, Iozzo R, Calabretta B. Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice Blood. 88: 1005-1012. DOI: 10.1182/Blood.V88.3.1005.1005 |
0.482 |
|
| 1996 |
Melotti P, Calabretta B. Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb Blood. 87: 2221-2234. DOI: 10.1182/Blood.V87.6.2221.Bloodjournal8762221 |
0.545 |
|
| 1995 |
Wen SC, Ku DH, De Luca A, Claudio PP, Giordano A, Calabretta B. ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A. Experimental Cell Research. 217: 8-14. PMID 7867724 DOI: 10.1006/Excr.1995.1057 |
0.446 |
|
| 1995 |
Raschellà G, Negroni A, Sala A, Pucci S, Romeo A, Calabretta B. Requirement of b-myb function for survival and differentiative potential of human neuroblastoma cells Journal of Biological Chemistry. 270: 8540-8545. PMID 7721753 DOI: 10.1074/Jbc.270.15.8540 |
0.497 |
|
| 1995 |
Venturelli D, Martinez R, Melotti P, Casella I, Peschle C, Cucco C, Spampinato G, Darzynkiewicz Z, Calabretta B. Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proceedings of the National Academy of Sciences of the United States of America. 92: 7435-9. PMID 7638209 DOI: 10.1073/Pnas.92.16.7435 |
0.43 |
|
| 1995 |
Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 92: 7016-20. PMID 7624361 DOI: 10.1073/Pnas.92.15.7016 |
0.464 |
|
| 1995 |
Perrotti D, Melotti P, Skorski T, Casella I, Peschle C, Calabretta B. Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity. Molecular and Cellular Biology. 15: 6075-87. PMID 7565760 DOI: 10.1128/Mcb.15.11.6075 |
0.509 |
|
| 1995 |
Sala A, Bellon T, Melotti P, Peschle C, Calabretta B. Inhibition of erythro-myeloid differentiation by constitutive expression of a DNA binding-deficient c-myb mutant: implication for c- myb function Blood. 86: 3404-3412. DOI: 10.1182/Blood.V86.9.3404.Bloodjournal8693404 |
0.409 |
|
| 1995 |
Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak M, Wen S, Zon G, Gewirtz A, Perussia B, Calabretta B. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells Blood. 86: 726-736. DOI: 10.1182/Blood.V86.2.726.Bloodjournal862726 |
0.44 |
|
| 1994 |
Skorski T, Kanakaraj P, Ku DH, Nieborowska-Skorska M, Canaani E, Zon G, Perussia B, Calabretta B. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. The Journal of Experimental Medicine. 179: 1855-65. PMID 8195713 DOI: 10.1084/Jem.179.6.1855 |
0.524 |
|
| 1994 |
Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B. Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide. Proceedings of the National Academy of Sciences of the United States of America. 91: 4504-8. PMID 8183938 DOI: 10.1073/Pnas.91.10.4504 |
0.403 |
|
| 1994 |
Citro G, Szczylik C, Ginobbi P, Zupi G, Calabretta B. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. British Journal of Cancer. 69: 463-467. PMID 8123474 DOI: 10.1038/Bjc.1994.84 |
0.491 |
|
| 1994 |
Melotti P, Ku D, Calabretta B. Regulation of the Expression of the Hematopoietic Stem Cell Antigen CD34: Role of c-myb Journal of Experimental Medicine. 179: 1023-1028. PMID 7509358 DOI: 10.1084/Jem.179.3.1023 |
0.451 |
|
| 1994 |
Soddu S, Blandino G, Citro G, Scardigli R, Piaggio G, Ferber A, Calabretta B, Sacchi A. Wild-Type p53 Gene Expression Induces Granulocytic Differentiation of HL-60 Cells Blood. 83: 2230-2237. DOI: 10.1182/Blood.V83.8.2230.Bloodjournal8382230 |
0.472 |
|
| 1993 |
Calabretta B, Skorski T, Szczylik C, Zon G. Prospects for gene-directed therapy with antisense oligodeoxynucleotides. Cancer Treatment Reviews. 19: 169-79. PMID 8481928 DOI: 10.1016/0305-7372(93)90033-N |
0.397 |
|
| 1993 |
Calabretta B, Venturelli D, Gewirtz AM. Functional Significance of c-myb Expression in Normal and Leukemic Hematopoiesis Cancer Investigation. 11: 191-197. PMID 8462020 DOI: 10.3109/07357909309024839 |
0.42 |
|
| 1993 |
Rizzo MG, Soddu S, Tibursi G, Calabretta B, Sacchi A. Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. Clinical & Experimental Metastasis. 11: 368-376. PMID 8375112 DOI: 10.1007/Bf00132980 |
0.483 |
|
| 1993 |
Skorski T, Nieborowska-Skorska M, Barletta C, Malaguarnera L, Szcyzlik C, Chen ST, Lange B, Calabretta B. Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide. The Journal of Clinical Investigation. 92: 194-202. PMID 8325984 DOI: 10.1172/Jci116549 |
0.468 |
|
| 1993 |
Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak M, Szczylik C, Zon G, Arlinghaus RB, Gewirtz A, Perussia B, Calabretta B. p120 GAP requirement in normal and malignant human hematopoiesis Journal of Experimental Medicine. 178: 1923-1933. PMID 8245773 DOI: 10.1084/Jem.178.6.1923 |
0.504 |
|
| 1993 |
Szczylik C, Skorski T, Ku DH, Nicolaides NC, Wen SC, Rudnicka L, Bonati A, Malaguarnera L, Calabretta B. Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb. The Journal of Experimental Medicine. 178: 997-1005. PMID 7688794 DOI: 10.1084/Jem.178.3.997 |
0.532 |
|
| 1992 |
Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G, Calabretta B. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proceedings of the National Academy of Sciences of the United States of America. 89: 7031-5. PMID 1495997 DOI: 10.1073/Pnas.89.15.7031 |
0.459 |
|
| 1992 |
Sala A, Calabretta B. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proceedings of the National Academy of Sciences of the United States of America. 89: 10415-10419. PMID 1438227 DOI: 10.1073/Pnas.89.21.10415 |
0.494 |
|
| 1992 |
Ratajczak M, Luger S, DeRiel K, Abrahm J, Calabretta B, Gewirtz AM. Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America. 89: 1710-1714. PMID 1371882 DOI: 10.1073/Pnas.89.5.1710 |
0.502 |
|
| 1992 |
Skorski T, Szczylik C, Ratajczak MZ, Malaguarnera L, Gewirtz AM, Calabretta B. Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides. The Journal of Experimental Medicine. 175: 743-50. PMID 1371302 DOI: 10.1084/Jem.175.3.743 |
0.353 |
|
| 1992 |
Nicolaides N, Correa I, Casadevall C, Travail S, Soprano K, Calabretta B. 43. JUND transactivates reporter gene expression driven by c-myb promoter via an Ap1-like element Biomedicine & Pharmacotherapy. 46: 259. DOI: 10.1016/0753-3322(92)90128-T |
0.395 |
|
| 1992 |
Raschella G, Negreni A, Skorski T, Pucci S, Nieborowska-Skorska M, Romeo A, Calabretta B. 31. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotidas in transformed neuroectodermal cell lines Biomedicine & Pharmacotherapy. 46: 253. DOI: 10.1016/0753-3322(92)90116-O |
0.411 |
|
| 1991 |
Gewirtz AM, Calabretta B. Role of the c-myb and c-abl protooncogenes in human hematopoiesis. Annals of the New York Academy of Sciences. 628: 63-73. PMID 2069323 DOI: 10.1111/J.1749-6632.1991.Tb17224.X |
0.382 |
|
| 1991 |
Calabretta B, Sims RR, Valtieri M, Caracciolo D, Szczylik C, Venturelli D, Ratajczak M, Beran M, Gewirtz AM. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proceedings of the National Academy of Sciences of the United States of America. 88: 2351-2355. PMID 2006173 DOI: 10.1073/Pnas.88.6.2351 |
0.541 |
|
| 1991 |
Travali S, Reiss K, Ferber A, Petralia S, Mercer WE, Calabretta B, Baserga R. Constitutively Expressed c-myb Abrogates the Requirement for Insulinlike Growth Factor 1 in 3T3 Fibroblasts Molecular and Cellular Biology. 11: 731-736. PMID 1990279 DOI: 10.1128/Mcb.11.2.731 |
0.475 |
|
| 1991 |
Nicolaides NC, Gualdi R, Casadevall C, Manzella L, Calabretta B. Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene. Molecular and Cellular Biology. 11: 6166-6176. PMID 1944282 DOI: 10.1128/Mcb.11.12.6166 |
0.486 |
|
| 1991 |
Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguarnera L, Venturelli D, Gewirtz AM, Calabretta B. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science (New York, N.Y.). 253: 562-5. PMID 1857987 DOI: 10.1126/Science.1857987 |
0.486 |
|
| 1991 |
Reiss K, Travali S, Calabretta B, Baserga R. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. Journal of Cellular Physiology. 148: 338-343. PMID 1717494 DOI: 10.1002/Jcp.1041480303 |
0.535 |
|
| 1991 |
Valtieri M, Venturelli D, Caré A, Fossati C, Pelosi E, Labbaye C, Mattia G, Gewirtz A, Calabretta B, Peschle C. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. Blood. 77: 1181-1190. DOI: 10.1182/Blood.V77.6.1181.1181 |
0.409 |
|
| 1990 |
Caracciolo D, Venturelli D, Valtieri M, Peschle C, Gewirtz A, Calabretta B. Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis. Journal of Clinical Investigation. 85: 55-61. PMID 2404028 DOI: 10.1172/Jci114433 |
0.499 |
|
| 1990 |
Gewirtz AM, Calabretta B. Molecular regulation of human megakaryocyte development. Stem Cells. 8: 267-276. PMID 2205664 DOI: 10.1002/Stem.5530080411 |
0.431 |
|
| 1990 |
Venturelli D, Travali S, Calabretta B. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression. Proceedings of the National Academy of Sciences of the United States of America. 87: 5963-5967. PMID 1696013 DOI: 10.1073/Pnas.87.15.5963 |
0.424 |
|
| 1990 |
Valtieri M, Gabbianelli M, Pelosi E, Testa U, Labbaye C, Mattia G, Fossati C, Peschle C, Venturelli D, Gewirtz AM, Calabretta B. Molecular mechanisms underlying erythropoiesis: cycling activity of adult BFU-e relates to their requirement for c-myb function and potential for HbF synthesis. Stem Cells. 8: 314-334. PMID 1691249 DOI: 10.1002/Stem.5530080730 |
0.374 |
|
| 1989 |
Caracciolo D, Valtieri M, Venturelli D, Peschle C, Gewirtz A, Calabretta B. Lineage-specific requirement of c-abl function in normal hematopoiesis. Science. 245: 1107-1110. PMID 2672339 DOI: 10.1126/Science.2672339 |
0.473 |
|
| 1989 |
Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb Science. 245: 180-183. PMID 2665077 DOI: 10.1126/Science.2665077 |
0.46 |
|
| 1989 |
Ku D, Travali S, Calabretta B, Huebner K, Baserga R. Human gene for proliferating cell nuclear antigen has pseudogenes and localizes to chromosome 20. Somatic Cell and Molecular Genetics. 15: 297-307. PMID 2569765 DOI: 10.1007/Bf01534969 |
0.301 |
|
| 1989 |
Anfossi G, Gewirtz AM, Calabretta B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proceedings of the National Academy of Sciences of the United States of America. 86: 3379-3383. PMID 2541445 DOI: 10.1073/Pnas.86.9.3379 |
0.538 |
|
| 1989 |
Gewirtz AM, Calabretta B, Rucinski B, Niewiarowski S, Xu WY. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. Journal of Clinical Investigation. 83: 1477-1486. PMID 2523411 DOI: 10.1172/Jci114041 |
0.466 |
|
| 1988 |
Venturelli D, Lange B, Narni F, Selleri L, Mariano MT, Torelli U, Gewirtz AM, Calabretta B. Prognostic significance of "short-term" effects of chemotherapy on MYC and histone H3 mRNA levels in acute leukemia patients Proceedings of the National Academy of Sciences of the United States of America. 85: 3590-3594. PMID 3285345 DOI: 10.1073/Pnas.85.10.3590 |
0.314 |
|
| 1988 |
Baserga R, Calabretta B, Travali S, Jaskulski D, Lipson KE, DeRIEL JK. Regulation of the expression of cell cycle genes. Annals of the New York Academy of Sciences. 551: 283-289. PMID 2907721 DOI: 10.1111/J.1749-6632.1988.Tb22354.X |
0.453 |
|
| 1988 |
Jaskulski D, deRiel J, Mercer W, Calabretta B, Baserga R. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin Science. 240: 1544-1546. PMID 2897717 DOI: 10.1126/Science.2897717 |
0.382 |
|
| 1988 |
Gewirtz A, Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro Science. 242: 1303-1306. PMID 2461588 DOI: 10.1126/Science.2461588 |
0.491 |
|
| 1988 |
Ferrari S, Calabretta B, Battini R, Cosenza SC, Owen TA, Soprano KJ, Baserga R. Expression of c-myc and induction of DNA synthesis by platelet-poor plasma in human diploid fibroblasts. Experimental Cell Research. 174: 25-33. PMID 2446899 DOI: 10.1016/0014-4827(88)90138-3 |
0.456 |
|
| 1987 |
Calabretta B, Mercer WE. TPA-induction of c-fos mRNA during the cell cycle of WI-38 human fibroblasts Biochemical and Biophysical Research Communications. 147: 716-723. PMID 3632695 DOI: 10.1016/0006-291X(87)90989-2 |
0.469 |
|
| 1987 |
Calabretta B. Dissociation of c-fos induction from macrophage differentiation in human myeloid leukemic cell lines. Molecular and Cellular Biology. 7: 769-774. PMID 3547082 DOI: 10.1128/Mcb.7.2.769 |
0.465 |
|
| 1987 |
Kaczmarek L, Calabretta B, Kao HT, Heintz N, Nevins J, Baserga R. Control of hsp70 RNA levels in human lymphocytes. The Journal of Cell Biology. 104: 183-7. PMID 3492498 DOI: 10.1083/Jcb.104.2.183 |
0.361 |
|
| 1987 |
Kaczmarek L, Elfenbein IB, Narni F, Vonderheid EC, Barry WE, Calabretta B. The effect of cytosine-arabinoside treatment on the overexpression of c-myc protooncogene in a case of prolymphocytic leukemia Cancer Genetics and Cytogenetics. 27: 89-99. PMID 3472650 DOI: 10.1016/0165-4608(87)90264-0 |
0.536 |
|
| 1987 |
Kaczmarek L, Calabretta B, Ferrari S, Riel JKd. Cell-cycle-dependent expression of human ornithine decarboxylase. Journal of Cellular Physiology. 132: 545-551. PMID 3308908 DOI: 10.1002/Jcp.1041320318 |
0.404 |
|
| 1987 |
Kaczmarek L, Calabretta B, Elfenbein I, Mercer WE. Cell cycle analysis of human peripheral blood T lymphocytes in long-term culture☆ Experimental Cell Research. 173: 70-79. PMID 2445595 DOI: 10.1016/0014-4827(87)90332-6 |
0.38 |
|
| 1986 |
Gibson CW, Rittling SR, Hirschhorn RR, Kaczmarek L, Calabretta B, Stiles CD, Baserga R. Cell cycle dependent genes inducible by different mitogens in cells from different species. Molecular and Cellular Biochemistry. 71: 61-9. PMID 3755218 DOI: 10.1007/Bf00219329 |
0.491 |
|
| 1986 |
Calabretta B, Venturelli D, Kaczmarek L, Narni F, Talpaz M, Anderson B, Beran M, Baserga R. Altered expression of G1-specific genes in human malignant myeloid cells Proceedings of the National Academy of Sciences of the United States of America. 83: 1495-1498. PMID 3513178 DOI: 10.1073/Pnas.83.5.1495 |
0.435 |
|
| 1986 |
Ferrari S, Battini R, Kaczmarek L, Rittling S, Calabretta B, Riel JKd, Philiponis V, Wei JF, Baserga R. Coding sequence and growth regulation of the human vimentin gene. Molecular and Cellular Biology. 6: 3614-3620. PMID 3467175 DOI: 10.1128/Mcb.6.11.3614 |
0.421 |
|
| 1986 |
Narni F, Kudo J, Mars W, Calabretta B, Florine DL, Barlogie B, Saunders GF. HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia. Blood. 68: 372-377. DOI: 10.1182/Blood.V68.2.372.Bloodjournal682372 |
0.357 |
|
| 1985 |
Kaczmarek L, Calabretta B, Baserga R. Effect of interleukin-2 on the expression of cell cycle genes in human T lymphocytes. Biochemical and Biophysical Research Communications. 133: 410-416. PMID 3878709 DOI: 10.1016/0006-291X(85)90921-0 |
0.389 |
|
| 1985 |
Calabretta B, Kaczmarek L, Mars W, Ochoa D, Gibson CW, Hirschhorn RR, Baserga R. Cell-cycle-specific genes differentially expressed in human leukemias. Proceedings of the National Academy of Sciences of the United States of America. 82: 4463-7. PMID 3859871 DOI: 10.1073/Pnas.82.13.4463 |
0.492 |
|
| 1985 |
Kaczmarek L, Calabretta B, Baserga R. Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 82: 5375-5379. PMID 2410921 DOI: 10.1073/Pnas.82.16.5375 |
0.474 |
|
| 1981 |
Torelli U, Torelli G, Narni F, Donelli A, Ferrari S, Franchini G, Calabretta B. Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. Haematology and Blood Transfusion. 26: 517-519. PMID 7319295 DOI: 10.1007/978-3-642-67984-1_95 |
0.365 |
|
| 1979 |
Torelli G, Narni F, Franchini G, Donelli A, Ferrari S, Calabretta B, Torelli U, Bosi P. Kinetics of hybridization to human DNA of heterogeneous nuclear RNA isolated from normal human lymphoblasts and acute leukemia blast cells. Molecular Biology Reports. 5: 181-184. PMID 290855 DOI: 10.1007/Bf00778420 |
0.327 |
|
| Show low-probability matches. |